Abiomed, Inc.
Option grant to new CEO reported under NASDAQ marketplace rule
Published in Pharma Investments, Ventures and Law Weekly, May 16th, 2004
These options were granted with the approval of the compensation committee of the board of directors and are in addition to 300,000 options granted Minogue under Abiomed's established employee stock option plan.
Terms of the inducement grant options are: exercise price equal to the fair market value on the grant date (April 5, 2004); 10-year duration; and vesting at the rate of 25% per year for the first 4 years of service with the company.
Based in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- Advanced Magnetics, Inc.
Nanobiotech company reports loss of $0.07 per share - Affymax, Inc.
Peptide drug maker completes Series C financing, adds new board member - Agentase, LLC
Biocatalyst maker receives $100,000 investment - Aksys, Ltd.
Dialysis systems developer files registration statement with SEC - AngioGenex, Inc.
Oncology company completes bridge financing - Avanir Pharmaceuticals
Pharmaceutical company files shelf registration statement - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
